Serum and CSF alpha-synuclein levels do not change in COVID-19 patients with neurological symptoms
Journal article published in 2021 by
V. A. Blanco-Palmero 
,
F. J. Azcárate-Díaz,
M. Ruiz-Ortiz ,
M. I. Laespada-García,
P. Rábano-Suárez,
A. Méndez-Guerrero,
M. Aramendi-Ramos,
J. L. Eguiburu,
A. Pérez-Rivilla,
A. Marchán-López,
M. Rubio-Fernández,
E. Carro,
J. González de la Aleja
,
F. J. Azcárate-Díaz,
M. Ruiz-Ortiz ,
M. I. Laespada-García,
P. Rábano-Suárez,
A. Méndez-Guerrero,
M. Aramendi-Ramos,
J. L. Eguiburu,
A. Pérez-Rivilla,
A. Marchán-López,
M. Rubio-Fernández,
E. Carro,
J. González de la Aleja
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 